News
Verywell Health on MSN4d
Enhertu Shows Promise as First-Line Treatment for Metastatic Breast CancerA combination of pertuzimab and Enhertu can slow disease progression and improve survival in people with HER2-positive ...
Acquired resistance to doxorubicin significantly reduces its therapeutic efficacy, limiting its clinical use in breast cancer treatment. Pan-AKR1C inhibitors have demonstrated potential in restoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback